Delivery Order SPE2DB20D7066-SPE2DB25FC1QD

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC1QD
    Delivery Order

This federal contract award, valued at $3,464.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566374364 - Ondansetron ODT 4 mg Tablets, a generic medication used to treat nausea and vomiting.

The contract has a firm fixed price and an ultimate completion date of November 12, 2024. Amerisourcebergen is the prime contractor, and the contract has no set-aside designation, indicating open competition.

In addition to this specific delivery order, Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/7/25, 9:14 AM